1. Home
  2. SUPN vs KARO Comparison

SUPN vs KARO Comparison

Compare SUPN & KARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • KARO
  • Stock Information
  • Founded
  • SUPN 2005
  • KARO 2001
  • Country
  • SUPN United States
  • KARO Singapore
  • Employees
  • SUPN N/A
  • KARO N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • KARO Computer Software: Prepackaged Software
  • Sector
  • SUPN Health Care
  • KARO Technology
  • Exchange
  • SUPN Nasdaq
  • KARO Nasdaq
  • Market Cap
  • SUPN 1.9B
  • KARO 1.7B
  • IPO Year
  • SUPN 2012
  • KARO 2021
  • Fundamental
  • Price
  • SUPN $33.56
  • KARO $46.44
  • Analyst Decision
  • SUPN Hold
  • KARO Strong Buy
  • Analyst Count
  • SUPN 2
  • KARO 3
  • Target Price
  • SUPN $36.00
  • KARO $57.67
  • AVG Volume (30 Days)
  • SUPN 681.6K
  • KARO 62.1K
  • Earning Date
  • SUPN 08-05-2025
  • KARO 07-22-2025
  • Dividend Yield
  • SUPN N/A
  • KARO 2.69%
  • EPS Growth
  • SUPN N/A
  • KARO 20.28
  • EPS
  • SUPN 1.11
  • KARO 1.73
  • Revenue
  • SUPN $667,997,000.00
  • KARO $264,205,688.00
  • Revenue This Year
  • SUPN N/A
  • KARO $20.68
  • Revenue Next Year
  • SUPN $15.74
  • KARO $15.64
  • P/E Ratio
  • SUPN $30.78
  • KARO $26.82
  • Revenue Growth
  • SUPN 11.82
  • KARO 11.00
  • 52 Week Low
  • SUPN $27.05
  • KARO $31.59
  • 52 Week High
  • SUPN $40.28
  • KARO $63.36
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 57.11
  • KARO 38.76
  • Support Level
  • SUPN $32.94
  • KARO $46.76
  • Resistance Level
  • SUPN $34.21
  • KARO $48.71
  • Average True Range (ATR)
  • SUPN 1.06
  • KARO 1.86
  • MACD
  • SUPN 0.04
  • KARO -0.34
  • Stochastic Oscillator
  • SUPN 56.90
  • KARO 7.16

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About KARO Karooooo Ltd.

Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.

Share on Social Networks: